Trump administration highlights: US President likely to make major announcement on Autism

According to media reports, Trump may also announce efforts to investigate how the cancer and anemia drug Leucovorin could potentially be used as a treatment for autism.

Babies who sleep less or have a poor quality of sleep could be at a higher risk of developing and being diagnosed with autism, according to researchers who looked at over 1000 mother-infant pairs in Australia.

According to reports from The Washington Post and Politico, the Trump administration is reportedly preparing to announce a connection between the use of the widely used pain reliever paracetamol during pregnancy and an increased risk of autism.

A paediatric therapy and inclusive education platform has launched a regulatory-approved technology to facilitate early screening of autism in India.

Federal health officials intend to award a contract to Rensselaer Polytechnic Institute to investigate whether there is a link between vaccinations and autism, AP reported citing a government procurement notice. The Troy, New York, engineering school is getting the no-bid contract because of its "unique ability" to link data on children and mothers, according to the notice posted this week.

According to media reports, Trump may also announce efforts to investigate how the cancer and anemia drug Leucovorin could potentially be used as a treatment for autism.

In April 2025, on the occasion of World Autism Awareness Day, Trump issued a statement expressing support for Americans affected by autism. He said that it is part of the American Dream that every child should be able to reach their full potential. During a cabinet meeting, Trump was assured that the causes of autism would be identified by September.

The US President said that tomorrow he will make the biggest medical announcement in American history. He believes that a solution to autism has been found.